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Position Statement from the Society for Developmental Biology on Genomic 
Editing in Human Embryos 
  
The Board of Directors of the Society for Developmental Biology (SDB) and the Editors of its 
official journal Developmental Biology are very concerned about the recently published study 
applying CRISPR/Cas9 genome editing technology to human embryos (1). SDB supports a 
voluntary moratorium by members of the scientific community on all manipulation of pre-
implantation human embryos by genome editing. Such studies raise deep ethical concerns on 
their own, and in addition could lead to unanticipated consequences if manipulated embryos 
were implanted into a womb and allowed to develop to term. 
Scientists worldwide apply genome editing technologies to a broad range of model organisms and 
human cells in culture, and these powerful tools hold great promise in helping to advance basic 
science knowledge and develop therapeutic approaches to human diseases and congenital defects. 
Some studies using these technologies in non-human embryos have reported unexpected genome 
disruptions, including gene deletions and creation of unintended mutations. This first published 
study (1) using CRISPR/Cas9 mediated-editing in human embryos reports even higher rates of 
unintended mutations than seen in those previous studies. These findings make further attempts to edit 
human embryos dangerous and unethical. 
While the published study utilized human embryos with three nuclei (tripronuclei-3PN) that cannot 
develop to term in order to minimize ethical concerns, SDB feels that the use of human embryos in 
genome engineering research opens the door to applications with current risks that are ethically 
unacceptable. It is important, however, that the public be educated on the positive uses of genome 
editing technologies in model organisms and in human somatic cells. Such uses hold enormous 
promise for advancing scientific knowledge. Legitimate concerns about applying genome editing to 
human embryos should not impede its use in basic science studies.  
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